Cerebral effects of a single dose of intravenous vinpocetine in chronic stroke patients: A PET study

Journal of Neuroimaging

Volumn 8, Issue 4, 1998, Pages 197-204

  Szakáll, Szabolcs ^a   Boros, István ^a   Balkay, László ^a   Emri, Miklós ^a   Fekete, István ^a   Kerényi, Levente ^a   Lehel, Szabolcs ^a   Márián, Teréz ^a   Molnár, Tamás ^a   Varga, József ^a   Galuska, László ^a   Trón, Lajos ^a   Bereczki, Dániel ^a   Csiba, László ^a   Gulyás, Balázs ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Blood brain barrier; PET; Stroke; TCD; Vinpocetine

Indexed keywords

VINPOCETINE; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN METABOLISM; CHRONIC DISEASE; CLINICAL ARTICLE; FEMALE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MALE; METABOLIC PARAMETERS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; BLOOD FLOW VELOCITY; BRAIN ISCHEMIA; BRAIN VASCULAR RESISTANCE; COMPARATIVE STUDY; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; KINETIC PARAMETERS; METABOLIC RATE; MOTOR DYSFUNCTION ASSESSMENT; MOTOR PERFORMANCE; NUCLEAR MAGNETIC RESONANCE SCANNER; ORGOGOZO STROKE SCALE; POSITRON CAMERA; REAL TIME ULTRASOUND SCANNER; SCANDINAVIAN STROKE SCALE; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT REFUSAL; TREATMENT RESPONSE; UNIFIED STROKE SCALE; VASCULAR RESISTANCE;

EID: 7344251894     PISSN: 10512284     EISSN: None     Source Type: Journal    
DOI: 10.1111/jon199884197     Document Type: Article

References (30)

1. Kuzuya F. Effects of vinpocetine on platelet aggregability and erythrocyte deformability. Ther Hung 1985;33:22-34
2. Szobor A, Klein M. Examinations of the relative fluidity in cerebrovascular disease patients. Ther Hung 1991;40:8-11
3. Hayakawa M. Effect of vinpocetine on red blood cell deformability in stroke patients. Arzneimittelforschung 1992; 42:425-427
4. Hayakawa M. Effect of vinpocetine on red blood cell deformability in vivo measured by a new centrifugation method. Arzneimittetforschung 1992;42:281-283
5. Jucker M, Meier-Ruge W, Baettig K. Relative regional changes in 2-deoxyglucose uptake reflect cognitive performances in aged and adult rats. Effects of brovincamine and vinpocetine. Psychopharmacology 1988;96:29 (Abstract)
6. Bíró K, Kárpati E, Szporny L. Protective activity of ethyl apovincaminate on ischaemic anoxia of the brain. Arzneimittelforschung 1976;26:1918-1920
7. Tohgi H, Sasaki K, Chiba K, Nozaki Y. Effect of vinpocetine on oxygen release of hemoglobin and erythrocyte organic polyphosphate concentrations in patients with vascular dementia of the Binswanger type. Arzneimittelforschung 1990;40:640-643
8. Miyamoto M, Murphy TH, Schnaar RL, Coyle JT. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J Pharmacol Exp Ther 1989;250:1132-1140
9. Nagy Z, ed. Stroke ellátás. [The Treatment of Stroke. In Hungarian]. Budapest: Springer Hungarica, 1994
10. Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. BMJ 1964;177
11. Orgogozo JM. Evaluation of treatments in ischemic-stroke patients. In: Amery WK, ed. Clinical trial methodology in stroke. London: Mallière Tindall, 1989:35-53
12. Scandinavian Stroke Study Group. Multicenter trial of hemodilution in ischemic stroke: background and study protocol. Stroke 1985;16:885-890
13. Edwards DF, Chen Y-W, Diringer MN. Unified neurological stroke scale is valid in ischemic and hemorrhagic stroke. Stroke 1995;26:1852-1858
14. Greitz T, Bergström M, Boëthius J, et al. Head fixation device for integration of radiodiagnostic and radiotherapeutic procedures. Neuroradiology 1980;19:1-6
15. Bergström M, Boëthius J, Eriksson J, et al. Head fixation device for reproducible positron alignment in transmission CT and positron emission tomography. J Comput Assist Tomogr 1981;5:136-141
16. Phelps ME, Huang SC, Hoffman EJ, et al. Tomographic measurements of local cerebral glucose metabolic rate in humans with 2-[F-18]ftuoro-2-deoxy-D-glucose: validation of method. Ann Neurol 1979;6:371-388
17. Huang SC, Phelps ME, Hoffman EJ, et al. Noninvasive determination of local cerebral glucose metabolic rate in man. Am J Physiol 1980;238:E69-E82
18. Roland PE, Friberg L. Localization of cortical areas activated by thinking. J Neurophysiol 1985;53:1219-1243
19. Rota Kops E, Herzog H, Schmid A, Holte S, Feinendegen LE. Performance characteristics of an eight-ring whole body PET scanner. J Comput Assist Tomogr 1990;14:437-445
20. 18 fluorode-oxyglucose. J Cereb Blood Flow Metab 1990;110:180-189
21. Balkay L, Molnár T, Boros I, et al. Quantification of FDG uptake using kinetic models. In: Gulyás B, Müller-Gärtner HW, eds. Positron emission tomography: a critical assessment of recent trends. Dordrecht: Kluwer, 1998;153-162
22. Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992;16:620-633
23. Emri M, Márián T, Kövér G. et al. Registration: a powerful tool to combine information provided by different imaging modalities. In: Gulyás B, Müller-Gärtner HW, eds. Positron emission tomography: a critical assessment of recent trends. Dordrecht: Kluwer, 1997:143-152
24. Matsuda H, Tsuji S, Shuke N, et al. Noninvasive measurement of regional cerebral blood flow using technetium-99m hexametilenpropil amine. Eur J Nucl Med 1993;20: 391-401
25. Catafau AM, Lomena FJ, Pavia J, et al. Regional cerebral blood flow pattern in normal young and aged volunteers: a HMPAO-SPECT study. Eur J Nucl Med 1996;23:1329-1337
26. Roland PE. Brain activation. New York: Wiley, 1993.
27. Gosling RG, King DH. Arterial assessment by Doppler-shift ultrasound. Proc R Soc Med 1974;67:447-449
28. Förstl H, Biedert S, Hewer W. Multiinfarct and Alzheimer-type dementia investigated by transcranial Doppler sonography. Biol Psychiatry 1989;26:590-594
29. Isaka Y, Okamoto M, Ashida K, Imaizumi M. Decreased cerebrovascular dilatory capacity in subjects with asymptomatic periventricular hyperintensities. Stroke 1994;25: 375-381
30. Newell DW, Aaslid R. Transcranial Doppler: clinical and experimental uses. Cerebrovasc Brain Metabol 1992;4:122-143